Additional chemokines and growth factors, such as TGF‐α, CCL4, CCL20, IL‐17A, IL‐2RB, and FGF‐23, further underscore the multifaceted interplay between inflammation and tumor biology through pathways ranging from proliferation and angiogenesis to immune cell recruitment [51–56]. This evidence concerns the gene FGF23 and neoplasm.